Papers
1
Total Citations
14
H-Index
1
About
Maura Rossi is a leading surgical oncologist whose research focuses on optimizing treatment protocols for rectal cancer, particularly the timing of surgery after neoadjuvant chemoradiotherapy. Her most cited work, the TiMiSNAR trial (2019, 14 citations), is a landmark multicenter randomized controlled study that directly compared standard 8-week versus prolonged 12-week intervals to minimally-invasive surgery following chemoradiation. This trial addresses a critical clinical controversy: whether allowing more time for tumor regression improves outcomes, including pathologic complete response rates. Rossi’s contributions have helped refine surgical timing, potentially reducing recurrence and improving quality of life for rectal cancer patients. Her work bridges the gap between retrospective observations and rigorous prospective evidence, influencing international guidelines. With a growing citation impact, Rossi is recognized for advancing evidence-based surgical oncology and for her leadership in collaborative, practice-changing trials that directly benefit patient care.
Research Focus
Key Achievements
Top Papers
- 1